Insider Selling: ICU Medical, Incorporated (NASDAQ:ICUI) Insider Sells 7,344 Shares of Stock

ICU Medical, Incorporated (NASDAQ:ICUI) insider Kevin J. Mcgrody sold 7,344 shares of the business’s stock in a transaction that occurred on Monday, June 10th. The stock was sold at an average price of $231.68, for a total value of $1,701,457.92. Following the sale, the insider now directly owns 7,574 shares in the company, valued at approximately $1,754,744.32. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.

NASDAQ:ICUI traded up $10.27 during midday trading on Tuesday, hitting $237.97. 237,603 shares of the stock were exchanged, compared to its average volume of 186,041. ICU Medical, Incorporated has a one year low of $210.94 and a one year high of $321.70. The stock has a market cap of $4.75 billion, a price-to-earnings ratio of 30.87 and a beta of 0.72.

ICU Medical (NASDAQ:ICUI) last posted its quarterly earnings results on Thursday, May 9th. The medical instruments supplier reported $2.35 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.96 by $0.39. The firm had revenue of $330.93 million for the quarter, compared to analyst estimates of $318.97 million. ICU Medical had a net margin of 4.04% and a return on equity of 13.70%. The firm’s quarterly revenue was down 11.0% compared to the same quarter last year. During the same quarter in the previous year, the business posted $2.26 earnings per share. On average, equities analysts predict that ICU Medical, Incorporated will post 8.55 earnings per share for the current fiscal year.



Several equities research analysts recently commented on ICUI shares. BidaskClub raised ICU Medical from a “hold” rating to a “buy” rating in a report on Wednesday, February 20th. Raymond James dropped their target price on ICU Medical from $315.00 to $300.00 and set a “strong-buy” rating on the stock in a report on Friday, March 1st. TheStreet raised ICU Medical from a “c+” rating to a “b” rating in a report on Friday, May 10th. Finally, Zacks Investment Research cut ICU Medical from a “buy” rating to a “hold” rating in a report on Wednesday, May 1st. Three equities research analysts have rated the stock with a hold rating and one has assigned a strong buy rating to the stock. ICU Medical presently has a consensus rating of “Buy” and a consensus price target of $281.00.

A number of institutional investors have recently bought and sold shares of the business. Cerity Partners LLC grew its position in ICU Medical by 4.5% in the first quarter. Cerity Partners LLC now owns 1,416 shares of the medical instruments supplier’s stock worth $339,000 after buying an additional 61 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank grew its position in ICU Medical by 6.5% in the first quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,118 shares of the medical instruments supplier’s stock worth $268,000 after buying an additional 68 shares during the last quarter. Utah Retirement Systems grew its position in ICU Medical by 2.9% in the first quarter. Utah Retirement Systems now owns 2,983 shares of the medical instruments supplier’s stock worth $714,000 after buying an additional 83 shares during the last quarter. Oregon Public Employees Retirement Fund grew its position in ICU Medical by 1.4% in the first quarter. Oregon Public Employees Retirement Fund now owns 6,646 shares of the medical instruments supplier’s stock worth $1,591,000 after buying an additional 90 shares during the last quarter. Finally, Advisory Services Network LLC grew its position in ICU Medical by 475.0% in the fourth quarter. Advisory Services Network LLC now owns 115 shares of the medical instruments supplier’s stock worth $27,000 after buying an additional 95 shares during the last quarter. Hedge funds and other institutional investors own 90.05% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “Insider Selling: ICU Medical, Incorporated (NASDAQ:ICUI) Insider Sells 7,344 Shares of Stock” was reported by Dakota Financial News and is the property of of Dakota Financial News. If you are accessing this article on another domain, it was stolen and reposted in violation of United States and international trademark & copyright legislation. The original version of this article can be accessed at https://dakotafinancialnews.com/2019/06/11/insider-selling-icu-medical-incorporated-nasdaqicui-insider-sells-7344-shares-of-stock.html.

ICU Medical Company Profile

ICU Medical, Inc develops, manufactures, and sells medical devices used in vascular therapy, critical care, and oncology applications worldwide. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient's vein.

Read More: LIBOR

Insider Buying and Selling by Quarter for ICU Medical (NASDAQ:ICUI)

Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.